GLP-1 Market
LLY $1150.99 ▼ -1.6% NVO $38.17 ▼ -3.1% PFE $28.18 ▲ +0.9% VKTX $41.65 ▲ +2.0% KLRA $13.13 ▲ +2.7% GPCR $35.95 ▼ -2.6% RHHBY $55.06 ▼ -0.9%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

ATR-258

ATR-258

Company
Morten Hostrup, PhD
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 24, 2026

Trial details
  • Completed NCT NCT05409924

    First-in-human Single and Multiple Dose Trial of ATR-258

    Not yet reported Atrogi AB 71 participants Est. completion 2023-10-04 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06432673

    The Attractive 2 Trial - Pharmacokinetics of ATR-258 Oral Capsule vs. Oral Solution Formulations in Healthy Volunteers

    Not yet reported Atrogi AB 21 participants Est. completion 2024-05-27 1 site Stand-alone
    Other conditions: Type2diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT07421024

    Biased GRK Signaling Via β2-Adrenergic Receptors in Human Skeletal Muscle

    Not yet reported Morten Hostrup, PhD 13 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Overweight and Obesity
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.